KrishnaRJuluriMDPhD

Hematologic Oncology

Director, Early Clinical Development at Bristol Myers Squibb

Dr. Juluri is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

University of WashingtonFellowship, Hematology and Medical Oncology, 2017 - 2021
Johns Hopkins University/Bayview Medical CenterResidency, Internal Medicine, 2015 - 2017
Johns Hopkins University School of MedicineClass of 2015

PubMed

153 citations
S-Nitrosylation of N-Ethylmaleimide Sensitive Factor Mediates Surface Expression of AMPA Receptors
Yunfei Huang, Heng-Ye Man, Yoko Sekine-Aizawa, Yefei Han, Krishna R. Juluri
Neuron. 2005-05-19
173 citations
Protein pyrophosphorylation by inositol pyrophosphates is a posttranslational event.
Rashna Bhandari, Adolfo Saiardi, Yousef Ahmadibeni, Adele M. Snowman, Adam C. Resnick
Proceedings of the National Academy of Sciences of the United States of America. 2007-09-25
85 citations
Poly(ADP-ribose) polymerase-1 is required for efficient HIV-1 integration
Hyo Chol Ha, Krishna R. Juluri, Yan Zhou, Steve W. Leung, Monika Hermankova
Proceedings of the National Academy of Sciences of the United States of America. 2001-03-13

Lectures

Severe Cytokine Release Syndrome Is Associated with Impaired Hematopoietic Recovery after CD19-Targeted CAR-T Cell Therapy
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Fred Hutch at ASH: Latest CAR T Data – BCMA, CD19, CD20 – plus New Insights on Transplantation, Gene Therapy – and MoreNovember 21st, 2019